Fisher Asset Management
RVMD icon

Fisher Asset Management’s Revolution Medicines RVMD Stock Holding History

Fisher Asset Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21M Sell
215,947
-25,110
-10% -$2.54M 0.01% 323
2025
Q4 		$19.2M Buy
241,057
+233,752
+3,200% +$15.3M 0.01% 328
2025
Q3 		$341K Buy
+7,305
New +$286K ﹤0.01% 858

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fisher Asset Management's RVMD Position: Q1 2026 in Review

Fisher Asset Management reduced its Revolution Medicines (RVMD) stake by 10% in Q1 2026, selling an estimated $2.54M and leaving 215,947 shares worth $21M. The position accounts for 0.01% of the portfolio, ranked #323.

Fisher Asset Management first reported a position in RVMD in Q3 2025 and has held it in 3 quarters since. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Fisher Asset Management held 215,947 shares of Revolution Medicines worth $21M as of Q1 2026.
  • Fisher Asset Management sold 25,110 Revolution Medicines shares in Q1 2026, an estimated $2.54M.
  • Revolution Medicines made up 0.01% of Fisher Asset Management's portfolio in Q1 2026, its #323 holding.
  • Fisher Asset Management first reported a position in Revolution Medicines in Q3 2025 and has held it in 3 quarters since.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Fisher Asset Management's 13F filing for Q1 2026, filed 5 May 2026.